These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11187050)
1. Values of markers of early and advanced glycation and lipoxidation in serum proteins of children with diabetes mellitus. Jakus V; Bauerova K; Michalkova D; Carsky J Bratisl Lek Listy; 2000; 101(9):484-9. PubMed ID: 11187050 [TBL] [Abstract][Full Text] [Related]
2. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus. Kostolanská J; Jakus V; Barák L J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of advanced glycation end products in poorly metabolically controlled children with diabetes mellitus: relation to HbA1c. Jakus V; Bauerová K; Michalková D; Cársky J Diabetes Nutr Metab; 2001 Aug; 14(4):207-11. PubMed ID: 11716290 [TBL] [Abstract][Full Text] [Related]
4. Glycation and lipid peroxidation in children and adolescents with type 1 diabetes mellitus with and without diabetic complications. Kostolanská J; Jakus V; Barák L J Pediatr Endocrinol Metab; 2009 Jul; 22(7):635-43. PubMed ID: 19774845 [TBL] [Abstract][Full Text] [Related]
5. Circulating TGF-β1, glycation, and oxidation in children with diabetes mellitus type 1. Jakuš V; Sapák M; Kostolanská J Exp Diabetes Res; 2012; 2012():510902. PubMed ID: 23049541 [TBL] [Abstract][Full Text] [Related]
6. Monitoring of early and advanced glycation in relation to the occurrence of microvascular complications in children and adolescents with type 1 diabetes mellitus. Kostolanská J; Jakus V; Barák L Physiol Res; 2009; 58(4):553-561. PubMed ID: 18657005 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of serum/plasma glycation and lipid peroxidation of young patients with type 1 diabetes mellitus in relation to glycemic compensation and the occurrence of diabetic complications. Kostolanska J; Jakus V; Barak L; Stanikova A; Waczulikova I Bratisl Lek Listy; 2010; 111(11):578-85. PubMed ID: 21384742 [TBL] [Abstract][Full Text] [Related]
8. Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control. Turk Z; Mesić R; Benko B Clin Chim Acta; 1998 Oct; 277(2):159-70. PubMed ID: 9853699 [TBL] [Abstract][Full Text] [Related]
9. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA. Galler A; Müller G; Schinzel R; Kratzsch J; Kiess W; Münch G Diabetes Care; 2003 Sep; 26(9):2609-15. PubMed ID: 12941727 [TBL] [Abstract][Full Text] [Related]
10. Early Formation of Serum Advanced Glycation End-Products in Children with Type 1 Diabetes Mellitus: Relationship with Glycemic Control. Jaisson S; Souchon PF; Desmons A; Salmon AS; Delemer B; Gillery P J Pediatr; 2016 May; 172():56-62. PubMed ID: 26947567 [TBL] [Abstract][Full Text] [Related]
11. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Domínguez C; Ruiz E; Gussinye M; Carrascosa A Diabetes Care; 1998 Oct; 21(10):1736-42. PubMed ID: 9773740 [TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications. Chiarelli F; de Martino M; Mezzetti A; Catino M; Morgese G; Cuccurullo F; Verrotti A J Pediatr; 1999 Apr; 134(4):486-91. PubMed ID: 10190925 [TBL] [Abstract][Full Text] [Related]
13. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes. Goodarzi MT; Navidi AA; Rezaei M; Babahmadi-Rezaei H J Clin Lab Anal; 2010; 24(2):72-6. PubMed ID: 20333759 [TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM. Berg TJ; Dahl-Jørgensen K; Torjesen PA; Hanssen KF Diabetes Care; 1997 Jun; 20(6):1006-8. PubMed ID: 9167115 [TBL] [Abstract][Full Text] [Related]
15. Could oxidative stress associate with age products in cataractogenesis? Gul A; Rahman MA; Hasnain SN; Salim A; Simjee SU Curr Eye Res; 2008 Aug; 33(8):669-75. PubMed ID: 18696342 [TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function. Brunvand L; Heier M; Brunborg C; Hanssen KF; Fugelseth D; Stensaeth KH; Dahl-Jørgensen K; Margeirsdottir HD BMC Cardiovasc Disord; 2017 May; 17(1):133. PubMed ID: 28545398 [TBL] [Abstract][Full Text] [Related]
18. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672 [TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus. Berg TJ; Bangstad HJ; Torjesen PA; Osterby R; Bucala R; Hanssen KF Metabolism; 1997 Jun; 46(6):661-5. PubMed ID: 9186302 [TBL] [Abstract][Full Text] [Related]
20. Positive Association Between Plasma Levels of Advanced Glycation and Precursor of Lipoxidation end Products with Gastrointestinal Problems in Children with Autism. Ghodsi R; Kheirouri S Curr Pediatr Rev; 2019; 15(3):184-190. PubMed ID: 31264551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]